Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Directions.

Current medical science - 1 Apr 2026

Xu Cheng-Yang, Zheng Bo, Chen Jia-le, Zhou Jie-Yi, Hu Guan-Qian, Yi Ke, Du Wei-Tong, He Jie, Li Rong

Abstract excerpt

Chromosome karyotyping, particularly G-banding, is a fundamental diagnostic and prognostic tool for hematological malignancies, providing a genome-wide view of large-scale numerical and structural chromosomal abnormalities. Its clinical utility is paramount for disease classification, risk stratification, and the evaluation of hematopoietic stem cell transplantation (HSCT) across diseases such as acute myeloid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Comparative Genomic Hybridization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Hematologic Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to In Situ Hybridization, Fluorescence

Share to Karyotyping

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 41926042
DOI: 10.1007/s11596-026-00188-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Directions.PMID 41926042Read ↗

Guiding the global evolution of cytogenetic testing for hematologic malignanciesSemantic proximity Read ↗

Cytogenetics in the genomics era: why karyotyping still mattersSemantic proximity Read ↗

Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mappingSemantic proximity Read ↗

Genome-wide arrays in routine diagnostics of hematological malignancies.Semantic proximity Read ↗

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Whole genome scanning as a cytogenetic tool in hematologic malignanciesSemantic proximity Read ↗

Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological MalignanciesSemantic proximity Read ↗

[The role of cytogenetic tests in the diagnosis of malignant hematologic diseases].Semantic proximity Read ↗

Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?Semantic proximity Read ↗

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNASemantic proximity Read ↗

Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Optical genome mapping in acute myeloid leukemia: a multicenter evaluationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.